Just to point out: I always find it shady when a paper uses an inert placebo / therapy as the control group rather than the current state of practice.

We'd ordinarily use at least - at least - an alpha-2 agonist like prazosin. Even going with just that would be malpractice-bordering conservative for severe PTSD.